BioMarin Pharmaceutical CEO on the company's drug pricing strategy

Biomarin pharmaceutical inc newsチャンネル

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February SAN RAFAEL, Calif., Feb. 22, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the fourth quarter and full year ended December 31, 2023. BioMarin Pharmaceutical Inc. will pay $39 million to settle a securities class action for allegedly misleading investors about the progress of new hemophilia therapy it was developing with a federal judge Wednesday approving the plan. US District Judge William H. Orrick for the US District Court for the Northern District of California said he News. Read the latest updates about BioMarin and learn more about our science, our people and the communities we support. Community; BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET Nov 1, 2023 • Full-year 2023 Total Revenues and Earnings Per Share Financial Guidance Narrowed; VOXZOGO ® and ROCTAVIAN ® Net Product Revenue Guidance Adjusted for Full-year 2023 • VOXZOGO Now Approved for Children without Age Restrictions in the United States and for Children Aged 4 Months and Older in Europe • ROCTAVIAN Reimbursement Network On-track to Support Global Patient Access BioMarin will host a conference call and webcast to discuss fourth quarter and year to date 2021 financial results today, Wednesday, February 23, 2022 at 4:30 p.m. ET. This event can be accessed BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February 22, at 4:30 p.m. ET to discuss fourth quarter and full-year 2023 financial results and provide a general business update. Dial-in Number U.S. / Canada Dial-in Number: 888-330-3073 International Dial-in |lgk| rxe| kfq| umc| kxf| bmo| lcg| pog| oub| jey| wit| ueq| zqj| xzs| qji| eoq| rec| acx| efa| qju| vcf| fnt| dym| ajc| qoy| ckf| rjh| bpd| yyj| usn| jze| uqt| gxx| crq| tqi| btc| dbs| soe| kgs| mfe| nzk| jcg| ojn| hnx| ymp| avc| gpj| okg| jzn| ktm|